Second-line protease inhibitor-based highly active antiretroviral therapy after failing non-nucleoside reverse transcriptase inhibitors-based regimens in Asian HIV-infected children

BACKGROUND: The WHO recommends boosted protease inhibitor (bPI)-based highly active antiretroviral therapy (HAART) after failing non-nucleoside reverse transcriptase inhibitor (NNRTI) treatment. We examined outcomes of this regimen in Asian HIV-infected children. METHODS: Children from five Asian co...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bunupuradah, Torsak, Puthanakit, Thanyawee, Fahey, Paul, Kariminia, Azar, Yusoff, Nik Khairulddin Nik, Khanh, Truong Huu, Sohn, Annette H., Chokephaibulkit, Kulkanya, Lumbiganon, Pagakrong, Hansudewechakul, Rawiwan, Razali, Kamarul, Kurniati, Nia, Huy, Bui Vu, Sudjaritruk, Tavitiya, Kumarasamy, Nagalingeswaran, Fong, Siew Moy, Saphonn, Vonthanak, Ananworanich, Jintanat
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3715593/
https://ncbi.nlm.nih.gov/pubmed/23296119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP2494
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares